18luck新利电竞主页平台管理系统 WANG TAO--英文主页--Paper Publications

WANG TAO

Recommended Ph.D.Supervisor Recommended MA Supervisor

·Paper Publications

Current position: 英文主页 > Scientific Research > Paper Publications

[1] 1. Li H, Chen LP, Yang J, Li MC, Chen RB, Lan RZ, Wang SG, Liu JH, Wang T.Predictive value of FSH, testicular volume, and histopathological findings for the sperm retrieval rate of microdissection TESE in nonobstructive azoospermia: a meta-analysis. Asian J Androl. 2017 Mar 24.[Epub ahead of print].
[2] 2. Wang T, Cai Y, Song W, Chen R, Hu D, Ye J, Liu L, Peng W, Zhang J, Wang S, Yang W, Liu J, Ding Y.Ethyl Acetate Extracts of Semen Impatientis Inhibit Proliferation and Induce Apoptosis of Human Prostate Cancer Cell Lines through AKT/ERK Pathways.Biomed Res Int. 2017;2017:1243515. IF=2.476.
[3] 3. Chen Z, Liu Q, Chen R, Liu Z, Li M, Ling Q, Wu L, Yang J, Liu X, Wang T, Hu Z, Guo X, Wang S, Yang W, Liu J.Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.World J Surg Oncol. 2017 Jan 26;15(1):33. IF=1.600.
[4] 4. Liu Z, Jiang H, Yang J, Wang T, Ding Y, Liu J, Wang S, Ye Z.Analysis of altered microRNA expression profiles in the kidney tissues of ethylene glycol-induced hyperoxaluric rats. Mol Med Rep. 2016; 14(5):4650-58. (*As corresponding author) IF=1.692 .
[5] 5. Wang T, Song W, Chen Y, Chen R, Liu Z, Wu L, Li M, Yang J, Wang L, Liu J, Ye Z, Wang C, Chen K. Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling.Clin Cancer Res. 2016 ;22(6):1531-44. IF=9.619 .
[6] 6. Chen R, Luan Y, Liu Z, Song W, Wu L, Li M, Yang J, Liu X, Wang T, Liu J, Ye Z. AR Pathway Is Involved in the Regulation of CX43 in Prostate Cancer. Biomed Res Int. 2015;2015:514234. (*As corresponding author) IF=2.476 .
[7] 7. Li MC, Wang ZY, Yang J, Guo XL, Wang T*, Wang SG, Liu JH*, Ye ZQ.Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysis. Asian J Androl. 2015;17(1):124-34. (*As corresponding author) IF=2.996 .
[8] 8. Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji JY, Wang C, Chen K.CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.Oncotarget. 2014;5(21):10293-306. IF=5.168 .
[9] 9. Wang T, Liu Z, Guo S, Wu L, Li M, Yang J, Chen R, Xu H, Cai S, Chen H, Li W, Wang L, Hu Z, Zhuang Q, Xu S, Wang L, Liu J, Ye Z, Ji JY, Wang C, Chen K.The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.Oncotarget. 2014;5(11):3611-21. IF=5.168 .
[10] 10. Wang T, Li M, Yuan H, Zhan Y, Xu H, Wang S, Yang W, Liu J, Ye Z, Li LC.saRNA guided iNOS up-regulation improves erectile function of diabetic rats.J Urol. 2013 Aug;190(2):790-8. IF=5.157 .

total48 1/5

firstpreviousnext last Page